Results 1 to 10 of about 50,041 (208)

Immunoglobulin G4-related renal disease masquerading as renal pelvic tumor [PDF]

Indian Journal of Urology, 2020
The recently recognized immunoglobulin G4 (IgG4)-related disease presenting as renal pelvic pseudotumor is rare. A definitive diagnosis is often difficult to obtain preoperatively, with patients being subjected to radical surgery due to suspicion of ...
Prashant Singh, Brusabhanu Nayak, Prabhjot Singh, Seema Kaushal, Sridhar Panaiyadiyan   +4 more
doaj   +4 more sources

Long‐Term Survival After Chemoradiotherapy for Renal Pelvis Cancer [PDF]

IJU Case Reports
Introduction Despite the recent increase in applicable chemotherapy regimens for renal pelvic and ureteral cancer, patients with metastases still exhibit a poor prognosis. Here, we report a patient with renal pelvic cancer for whom long‐term survival was
Yukinobu Shimada, Hiroyuki Kitano, Shunsuke Miyamoto, Kohei Kobatake, Keisuke Goto, Akihiro Goriki, Keisuke Hieda, Yutaka Hirokawa, Nobuyuki Hinata   +8 more
doaj   +2 more sources

Overall and Cancer-Specific Survival in Patients With Renal Pelvic Transitional Cell Carcinoma: A Population-Based Study

Frontiers in Medicine, 2022
Background: Renal pelvic transitional cell carcinoma (TCC) is a relatively rare tumor. This study aimed to develop two prognostic nomograms to predict overall survival (OS) and cancer-specific survival (CSS) in renal pelvic TCC patients.Methods ...
Tingting Hu, Shengjie You
doaj   +1 more source

Rare cause of ascites and pleural effusion: The first case report and literature review of pseudo–pseudo Meig's syndrome in Taiwan

Journal of the Formosan Medical Association, 2022
Pseudo–pseudo Meigs' syndrome (PPMS) exhibits patients with ascites, pleural effusion, elevated CA-125, and diagnosed of systemic lupus erythematosus (SLE) eventually without evidence of ovarian or pelvic tumor.
Yi-Hsiang Chao, Hsin-Yu Chen
doaj   +1 more source

Misdiagnosis of renal pelvic unicentric Castleman disease: a case report

Frontiers in Surgery, 2023
Castleman disease is a rare heterogeneous lymphoproliferative disorder of unknown etiology. Unicentric Castleman disease (UCD) is more common. UCD can occur at any site where lymphatic tissue exists, most commonly in the mediastinum, neck, and abdominal ...
Dian Fu, Dian Fu, Bo Yang, Ming Yang, Zhenyu Xu, Wen Cheng, Zhijia Liu, Liming Zhang, Zhiguo Mao, Cheng Xue   +9 more
doaj   +1 more source

Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy

Scientific Reports, 2021
Tumor multifocality and location are prognostic factors for upper tract urothelial carcinoma (UTUC). However, confounding effects can appear when these two factors are analyzed together. Therefore, we aimed to investigate the impact of tumor distribution
Zai-Lin Sheu, Chi-Ping Huang, Chao-Hsiang Chang, Chung-Hsin Chen, Jian-Hua Hong, Han-Yu Weng, Ta-Yao Tai, Shiu-Dong Chung, Chi-Wen Lo, Thomas Y. Hsueh, Yao-Chou Tsai, Yuan-Hong Jiang, Bing-Juin Chiang, Yung-Tai Chen, Jen-Tai Lin, Wei-Yu Lin, Yeong-Chin Jou, Jen-Shu Tseng, Chia-Chang Wu, Wen‑Jeng Wu, Hsin‑Chih Yeh   +20 more
doaj   +1 more source

Potentiation of the abscopal effect by modulated electro-hyperthermia in locally advanced cervical cancer patients [PDF]

, 2020
Background: A Phase III randomized controlled trial investigating the addition of modulated electro-hyperthermia (mEHT) to chemoradiotherapy for locally advanced cervical cancer patients is being conducted in South Africa (Human Research Ethics Committee
Ayeni, Olusegun, Baeyens, Ans, Kotzen, Jeffrey, Minnaar, Carrie Anne, Vangu, Mboyo-Di-Tamba   +4 more
core   +2 more sources

Remarkable response to fluorouracil, leucovorin, oxaliplatin, and irinotecan therapy in urothelial cancer of the renal pelvis: a case report

Journal of Medical Case Reports, 2017
Background No standard chemotherapy regimen for advanced urothelial cancer has been established, except for cisplatin-based regimens. We report the case of a patient with double primary cancer, urothelial carcinoma of the upper urinary tract and ...
Takuya Tsujino, Kiyoshi Takahara, Tomohisa Matsunaga, Yuki Yoshikawa, Tomoaki Takai, Taizo Uchimoto, Kenkichi Saito, Naoki Tanda, Hajime Hirano, Hayahito Nomi, Naokazu Ibuki, Teruo Inamoto, Haruhito Azuma   +12 more
doaj   +1 more source

Case report: Significant benefits of tislelizumab combined with anlotinib in first-line treatment of metastatic renal pelvic urothelial carcinoma with sarcomatoid carcinoma differentiation

Frontiers in Oncology, 2022
BackgroundRenal pelvic urothelial carcinoma with sarcomatoid carcinoma differentiation is a very dangerous malignant tumor and extremely rare in clinical practice.
Shibin Zhu, Chenhao Yu, Chongwei Wang, Guoqing Ding, Sheng Cheng   +4 more
doaj   +1 more source

Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal pelvic and ureteral tumors in upper tract urothelial carcinoma

BMC Urology, 2018
Background There's no consensus about the difference between renal pelvic and ureteral tumors in terms of clinical features, pathological outcomes, epigenetic biomarkers and prognosis.
Dong Fang, Shiming He, Gengyan Xiong, Nirmish Singla, Zhenpeng Cao, Lei Zhang, Xuesong Li, Liqun Zhou   +7 more
doaj   +1 more source